Douglas Berger Psychiatrist Tokyo – About Dr. Douglas Berger

Douglas-Berger-Tokyo-psychiatrist
Douglas Berger psychiatrist Tokyo

Dr. Douglas Berger, M.D., Ph.D., Meguro Counseling Center Director

Douglas Berger, M.D., Ph.D., a fully bilingual American board certified psychiatrist, is the Director of the Tokyo Meguro Counseling Center. Dr. Doug Berger is a graduate of New York Medical College where he completed a 4-year residency program in psychiatry. He then finished a fellowship in Psychosomatic Medicine at the Albert Einstein College of Medicine. Now based in Tokyo, he had served on the Faculty of the Albert Einstein College of Medicine Department of Psychiatry in New York as an Assistant Professor of Psychiatry and licensed practicing U.S. physician. Dr. Berger’s Japanese qualifications include a Ph.D. from the University of Tokyo School of Medicine received for psychiatric research done while at the Tokyo University Department of Psychosomatic Medicine.

Dr. Berger came to Japan as a medical exchange student and psychiatric researcher at the Tokai University School of Medicine on a research fellowship from the Matsumae International Foundation. He later returned to Japan to do further psychiatric research at the Tokyo University Department of Psychosomatic Medicine and the Tokyo Institute of Psychiatry. Dr. Berger speaks native-level Japanese and regularly conducts psychotherapy for mixed-cultural couples as well as the local Japanese community. This page lists Dr. Berger’s research activity, and this page is an archive of community education articles for the Tokyo Families Magazine written by Dr. Berger. See what we write about on Twitter: Dr. Berger’s Twitter Page Meguro Counseling Center Twitter Page.

Dr. Berger also works extensively with children as Director of the Tokyo Child & Adolescent Counseling Service. Dr. Berger is a legal permanent resident of Japan.

Credential Verifications

Dr. Berger’s medical degree is from the United States, he is well-versed in the use of psychiatric medication and can guide the use of psychiatric medications integrated with psychotherapy through the physicians affiliated with his counseling practice (he does not directly practice medical care in Japan). Further information on Dr. Berger can be seen on his personal home page.

Publications by Dr. Douglas Berger, psychiatrist in Tokyo

Berger D: DOUBLE-BLINDING AND BIAS IN MEDICATION AND COGNITIVE-BEHAVIORAL THERAPY TRIALS FOR MAJOR DEPRESSIVE DISORDER, F1000Research 2016, 4:638 (doi: 10.12688/f1000research.6953.2). U.S. National Library of Medicine version.

Berger D: DOUBLE BLINDING REQUIREMENT FOR VALIDITY CLAIMS IN COGNITIVE-BEHAVIORAL THERAPY INTERVENTION TRIALS FOR MAJOR DEPRESSIVE DISORDER. Analysis of Hollon S, et al., Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial, F1000Research 2015, 4:639 (doi: 10.12688/f1000research.6954.1). U.S. National Library of Medicine version.

Articles by Douglas Berger, M.D., Ph.D. for Tokyo Families magazine.

Click here to see a full list of articles.

For more information on Dr. Doug Berger, read some of the articles here.

To contact Douglas Berger psychiatrist Tokyo please click here

Counseling In Tokyo: Bipolar disorder has equal rates in men and women, unipolar depression is more common in women https://t.co/JbM1dBqskB

Therapy in Tokyo: Vagal nerve stimulation can treat refractory partial epilepsy and intractable depression https://t.co/yr4bvJUrvn

Vagal nerve stimulation can treat refractory partial epilepsy and intractable depression. Only the left Vagal nerve is stimulated on a 30 sec on-5 min off cycle throughout the day. Us: https://t.co/uaoP3ZdWvx, https://t.co/EM6ss7NILt

Todd’s paralysis is a short and transient hemiplegia seen after a seizure. Post-ictal A-V shunting may be the cause. Us: https://t.co/EM6ss7NILt, https://t.co/eGw7GaNOQn

Load More...

Psychiatric medications have multiple effects on sexual desire and function due anticholinergic and antiadrenergic effects. Us: https://t.co/urVpIxQD7G, https://t.co/tReJReVhnP

Tyrosine hydroxylase (rate limiting) converts tyrosine to L-DOPA, DOPA decarboxylase makes dopamine from L-DOPA, and dopamine B-hydroxylase makes norepinephrine from dopamine. One happy neurotransmitter family. Us: https://t.co/tReJRfcSMp, https://t.co/RyG3aQKKUl

My article in #F1000Research has been viewed more than 1000 times. https://t.co/yHjSiYJuY3

Load More...